Sign in Subscribe
Cancer research

Breakthrough in Colon Cancer Diagnosis: Multivariate Prediction Method Develops

Strategic Insights

— 1 min read

Researchers at Capital Medical University in Beijing, People's Republic of China, have made a significant discovery in the field of colon cancer diagnosis. According to the study, a multivariate prediction method has been developed to improve the diagnostic accuracy of colorectal cancer. The research team, led by Junyue Xu, used a combination of fecal immunochemical test, M3 gene expression, and KRAS mutation analysis, as well as tumor methylation burden in blood, to develop a predictive model that outperformed individual markers. The study found that combining M3, methylation-burden, and KRAS-mutation resulted in the highest diagnostic accuracy, particularly for early colon cancer patients.

Key Takeaways:

  • A new multivariate prediction method has been developed for diagnosing colorectal cancer, combining fecal immunochemical test, M3 gene expression, KRAS mutation analysis, and tumor methylation burden in blood.
  • The method showed improved diagnostic accuracy compared to individual markers, with the combination of M3, methylation-burden, and KRAS-mutation reaching the highest AUC value.
  • Early colon cancer patients particularly benefited from this predictive model, with an AUC value of 0.931.
  • The study's results suggest that this multivariate approach could be a reliable method for early colon cancer diagnosis.
  • The research was conducted by Junyue Xu and colleagues at Capital Medical University and was published in Frontiers in Immunology.

Statistics:

  • 197 CRC samples were enrolled in the study to evaluate the diagnostic performance of the predictive model.
  • The AUC value for the combination of M3, methylation-burden, and KRAS-mutation was 0.920 for all patients and 0.931 for early CRC patients.
  • The predictive model showed a significant enhancement in diagnostic performance when combining multiple markers versus individual markers.
  • The study highlights the importance of multivariate analysis in improving diagnostic accuracy for colon cancer.

Sources:

  • Junyue Xu et al., "Diagnostic accuracy evaluation of individual or combinational fecal immunochemical test, M3 gene, KRAS mutation and tumor methylation burden in colorectal carcinoma." Frontiers in Immunology, 2025, 16. (Frontiers in Immunology - http://journal.frontiersin.org/journal/immunology)
  • NewsRx, "Data on Colon Cancer Published by Researchers at Capital Medical University (Diagnostic accuracy evaluation of individual or combinational fecal immunochemical test, M3 gene, KRAS mutation and tumor methylation burden in colorectal carcinoma)." Health & Medicine Week, August 8, 2025; p 887.

Read more